PIPERAZINE, [1,4]DIAZEPANE, [1,4]DIAZOCANE, AND [1,5]DIAZOCANE FUSED IMIDAZO RING COMPOUNDS,申请号WO2004US43474-传众专利搜索

PIPERAZINE, [1,4]DIAZEPANE, [1,4]DIAZOCANE, AND [1,5]DIAZOCANE FUSED IMIDAZO RING COMPOUNDS

申请公布号：WO2005066172(A1)

申请号：WO2004US43474

申请日期：2004.12.22

申请公布日期：2005.07.21

申请人：

3M INNOVATIVE PROPERTIES COMPANY;KSHIRSAGAR, TUSHAR A.,;GRIESGRABER, GEORGE W.,;CELEBI, ABDULAZIZ A.,;HEPPNER, PHILIP D.,

发明人：KSHIRSAGAR, TUSHAR A.,;GRIESGRABER, GEORGE W.,;CELEBI, ABDULAZIZ A.,;HEPPNER, PHILIP D.,

分类号：A61K31/551;C07D471/14;C07D471/22;(IPC1-7):C07D471/14;A61P31/12;A61P35/00

主分类号：A61K31/551

摘要：<p>Piperazine, [1,4]diazepane, [1,4]diazocane, and [1,5]diazocane fused imidazo ring compounds (i.e., imidazoquinolines, tetrahydroimidazoquinolines, imidazonaphthyridines, tetrahydroimidazonaphthyridines, and imidazopyridines), pharmaceutical compositions containing the compounds, intermediates, methods of making, and methods of use of these compounds as immunomodulators, for inducing or inhibiting cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.</p>